
Fresh or Filthy? Proper Bath Towel Hygiene
Even though your bathroom towels may look clean, they could be holding massive amounts of bacteria and germs. Here's everything to know about how often you should wash your bath towels to keep them in tip-top shape. Plus, the best temperature for getting them the cleanest.
Why do you need to clean your bath towels so often?
When you dry off with towels, they get moist. This porous, damp environment is the perfect breeding ground for bacteria. A common bath towel can have yeast, mold and E. coli growing on it without you ever knowing it. Gross, right? Regular washing prevents bacteria from growing.
LG's WashTower functions as one combined washer and dryer unit.
LG
When should you reuse or wash bathroom towels?
Consumer Reports says that under normal circumstances, a towel can be used three or four times before it needs to be washed. That's "times" not "days." If you have many family members using a towel (like hand towels), it needs to be washed on the third or fourth use.
The condition of the person using the towel matters, too. If they're sick, toss it in the laundry after one use. If it's flu season, it's best for every family member to have their own towel -- even if they aren't exhibiting symptoms -- to prevent the potential spread of germs.
How often you wash towels also depends on how they're dried after usage. If towels find themselves on the floor, the lack of air circulation will cause bacteria to grow quickly. To prolong the life of your towel, be sure to place damp towels on a towel rack. Better yet, crack open a window or turn on the fan to reduce moisture in the room.
Supercharge your dryer by cleaning its vent Supercharge your dryer by cleaning its vent
Click to unmute
Video Player is loading.
Play Video
Play
Skip Backward
Skip Forward
Next playlist item
Unmute
Current Time
0:00
/
Duration
1:37
Loaded :
24.52%
0:00
Stream Type LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
1:37
Share
Fullscreen
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text
Color White Black Red Green Blue Yellow Magenta Cyan
Opacity Opaque Semi-Transparent Text Background
Color Black White Red Green Blue Yellow Magenta Cyan
Opacity Opaque Semi-Transparent Transparent Caption Area Background
Color Black White Red Green Blue Yellow Magenta Cyan
Opacity Transparent Semi-Transparent Opaque
Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps
Reset Done
Close Modal Dialog
End of dialog window.
Close Modal Dialog
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Close Modal Dialog
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Supercharge your dryer by cleaning its vent
What temperature is best for washing bath towels?
The Infection Control department of Mid-Western Regional Hospital of Ennis, Ireland, recommends washing towels in water that is at least 140 degrees Fahrenheit (60 degrees Celsius) or more to kill bacteria. So if you have a sanitize mode on your washing machine, use it. If not, you may consider raising the temperature on your water heater while washing that load. Be sure young children are supervised around sinks, tubs and showers while you do laundry, though, to prevent burns.
And, before you reach for the fabric softener, don't. Fabric softener leaves residue on towels that makes them less absorbent.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
3 minutes ago
- Associated Press
Scientist.com Expands Tumor Model Finder with XenoSTART's Highly Relevant, Patient-Derived Tumor Models
SAN DIEGO--(BUSINESS WIRE)--Jul 23, 2025-- the leading R&D procurement orchestration platform for the life sciences, today announced a major expansion of its Tumor Model Finder (TMF) following a strategic partnership with XenoSTART, a global leader in patient-derived xenograft (PDX) model development and testing. The addition of hundreds of unique and high-demand XenoSTART models pushes the TMF past a milestone of 10,000 searchable oncology models, giving cancer researchers unprecedented access to diverse and clinically relevant tools. 'Pharma discovery teams often face critical delays accessing translational research partners with deeply characterized PDX models that accurately reflect real-world patient disease complexity,' said Michael J. Wick, PhD, Chief Scientific Officer at XenoSTART. 'By joining the marketplace, XenoSTART eliminates this significant barrier, providing immediate access to our highly relevant, patient-derived tumor models that are directly linked to our global clinical network. This integration empowers drug developers to confidently accelerate therapeutic decision-making and precisely guide their translational strategies—ultimately speeding effective cancer treatments to patients.' Tumor Model Finder is a centralized, AI-powered platform that aggregates and standardizes tumor model data from 20+ leading CROs. It allows researchers to search, compare, and source PDX, CDX, organoid, and cell line models—spanning 17 cancer types—through a single workflow. The platform also includes drug response profiles, genomic alterations (e.g., KRAS, BRAF mutations), and RNA seq-based gene expression data to support informed model selection and study design. 'XenoSTART's contribution significantly boosts the depth and quality of our TMF offerings,' said Javier Pineda, PhD, Director of Preclinical AI at 'Researchers can now find models with richer data and greater relevance to their specific cancer studies.' This collaboration also highlights the translational impact of START's global research ecosystem. With patient-derived tissue samples sourced from START's expansive oncology trial network, XenoSTART's models provide critical continuity between preclinical evaluation and clinical trial execution—helping pharmaceutical companies make faster, more confident decisions in oncology drug development. To learn more or schedule a demo of the Tumor Model Finder, email [email protected]. About is the life-science industry's premier AI-powered marketplace and procurement-orchestration platform. Founded in 2007 and headquartered in Solana Beach, California, the company simplifies every stage of drug discovery and development by unifying supplier search, competitive bidding, contracting, compliance and analytics in a single, secure workspace. More than 20 of the world's top 30 pharma companies, 100+ biotech organizations and the US National Institutes of Health rely on to access a vetted network of 6,000+ specialized providers, shorten cycle times and reduce costs while meeting the highest ethical and regulatory standards. Visit to discover how we accelerate science. About XenoSTART Founded in 2007, XenoSTART is a translational research organization dedicated to advancing oncology drug development through clinically relevant preclinical cancer models. The XenoSTART Patient-Derived Xenograft (XPDX) platform features more than 2,800 models across a broad range of tumor types and disease stages sourced from patients treated at START's domestic and international cancer centers. Models are deeply characterized using histologic analysis, DNA/RNA sequencing, and in vivo drug sensitivity testing, and are clinically annotated with the donor patient's treatment history and clinical outcome. By bridging real-world tumor biology with rigorous preclinical science, XenoSTART enables pharmaceutical partners to make smarter, faster decisions from bench to bedside. Learn more about XenoSTART at View source version on CONTACT: Sean Preci +1 877-644-3044 [email protected] XenoSTART Lauren Panco 609-216-4920 KEYWORD: EUROPE UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: OTHER HEALTH RESEARCH PHARMACEUTICAL ONCOLOGY TECHNOLOGY ARTIFICIAL INTELLIGENCE GENETICS HEALTH TECHNOLOGY SCIENCE BIOTECHNOLOGY OTHER SCIENCE HEALTH SOURCE: Copyright Business Wire 2025. PUB: 07/23/2025 07:55 AM/DISC: 07/23/2025 07:55 AM


Medscape
3 minutes ago
- Medscape
Could Ketamine Addiction Become the UK's Next Drug Crisis?
Doctors are warning that ketamine is not the harmless party drug many believe it to be, as rising numbers of young people in the UK are being treated for addiction and serious organ damage. Despite the surge in use, many users — and even frontline clinicians — remain unaware of the drug's addictive potential and its severe physical health consequences, including bladder failure, kidney damage, and extreme weight loss. According to the Home Office, an estimated 299,000 people aged 16-59 had reported ketamine use in the year ending March 2023 – the largest number on record. In a June 2025 editorial in The BMJ , addiction psychiatrists said that 3609 people began treatment for ketamine addiction in 2023-2024. That is more than eight times the number recorded in 2014-2015. The drug's relatively low cost made it popular among young people, according to the experts from King's College London and South London and Maudsley NHS Foundation Trust. 'Not Just a Party Drug' Dr Irene Guerrini Consultant addiction psychiatrist Dr Irene Guerrini, who led the study, told Medscape News UK : 'The vast majority of clinicians think ketamine is a party drug used at clubs and raves, but it's not just that. My young patients often go to A&E and primary care and are told ketamine is not addictive, but it is addictive and can cause serious harm.' Guerrini said that ketamine uropathy is the most common complication of frequent use. 'It causes serious bladder, kidney and liver problems, and often extreme weight loss, which can be confused with an eating disorder by some health professionals.' Earlier this month, Alder Hey children's hospital in Liverpool opened a specialist ketamine clinic to treat young people under 16 for ketamine-induced uropathy. Physical and Psychological Harm A separate study by the University of Exeter and University College London (UCL), published in the journal Addiction in April, also found a strong link between ketamine addiction and physical and psychological health problems. Among 274 people with ketamine use disorder, 60% had experienced bladder or nasal problems. More than half (56%) reported painful cramping in the abdomen, known as 'k-cramps'. Chemicals released when ketamine breaks down in the body can damage the bladder lining, leading to pain, bleeding, and scarring. Some bladder damage was so severe that it required bladder removal and the use of a urostomy bag. Celia Morgan Study author Professor Celia Morgan, of the University of Exeter told Medscape News UK , ' Ketamine use is increasing. We have observed users are younger and the trajectory to dependence seems fast in some individuals. 'In those who are sucked in to repeated heavy ketamine use, the physical consequences are severe in terms of bladder complications, but also dramatic weight loss and in severe cases, multi-organ failure.' Sharp Rise in Rehab Admissions UK Addiction Treatment (UKAT) centres have reported a surge in people seeking help. Zaheen Ahmed Zaheen Ahmed, director of addiction treatment at UKAT, told Medscape News UK that there had been ' a staggering rise in both enquiries for help and admissions into our centres'. Admissions were up 35% in 2024 compared with the previous year. 'Ketamine addiction has become the norm, and we're seeing it and treating it daily now,' he said. Ahmed warned, 'Ketamine is a really dangerous drug, because it doesn't give the user an awful come down like other substances do.' The drug is also 'incredibly cheap, making it very appealing, especially to young people'. Medical Use and Misuse Ketamine is used clinically as an anaesthetic. At lower doses, it is prescribed for chronic pain, treatment-resistant depression, and suicidality. It is also being trialled in studies to treat post-traumatic stress disorder (PTSD) and severe alcohol dependence. However, experts have warned that increasing availability through private clinics may normalise unsupervised or self-directed use. The drug has also been linked to the deaths of Friends actor Matthew Perry and drag performer The Vivienne. Missed Diagnoses in Primary Care The Exeter/UCL Study found that most people with ketamine use disorder do not seek treatment. Existing services are often perceived as ineffective. 'In our study, a common report was that doctors and health professionals were ignorant to ketamine addiction and its physical health impacts,' said Morgan. 'We need to urgently raise awareness and educate professionals of this often devastating and life-threatening condition.' Guerrini agreed that doctors should be more alert to the possibility of ketamine addition. 'M aybe if I'm a GP and see a particularly young patient coming to me with a urinary tract problem like cystitis, be I'll be more inquisitive, ask the correct questions, and think maybe this patient is on ketamine.' Similarly, A&E doctors should develop 'clinical curiosity' if a young patient has high liver enzymes and severe pain. Guerrini called for better diagnostic tools, a national registry, and earlier screening to support treatment and help evaluate emerging therapies. 'It's important to increase awareness among professionals and encourage joined up working between substance misuse services, urology services, and mental health services, as these young people often have chronic depression along with physical issues caused by ketamine,' she said. Government Considering Reclassification Ketamine is currently controlled as a Class B substance. The maximum penalty for supplying and producing it is up to 14 years in prison, an unlimited fine, or both. Earlier this year, the Home Office asked independent experts for advice on whether ketamine should remain controlled as a Class B substance or become a Class A drug. Ahmed said that reclassification would increase penalties for dealers, but more importantly, ' it will hopefully discourage young people especially to even experiment with it at all'.

Associated Press
5 minutes ago
- Associated Press
Avel eCare Appoints Martainn Lenhardt as Chief Financial Officer to Lead Financial Strategy Amid Rapid Growth and Innovation
SIOUX FALLS, SD / ACCESS Newswire / July 23, 2025 / Avel eCare, a leading provider of telemedicine services in the United States, today announced the appointment of Martainn Lenhardt as Chief Financial Officer (CFO). Lenhardt brings over 20 years of healthcare finance experience to the role, where he will oversee Avel's financial strategy, operations, and performance during a pivotal era of innovation and nationwide expansion. Lenhardt joins Avel eCare following his tenure as VP of Finance at Lyric and senior leadership roles at Change Healthcare, where he managed a $480 million business unit and was instrumental in driving growth and improving margins. He is widely recognized for his expertise in strategic growth, mergers and acquisitions, and optimizing global operations. His ability to turn complexity into opportunity and build agile, purpose-driven teams will be instrumental in advancing Avel's mission. 'Avel eCare is transforming how healthcare is delivered across the country,' said Lenhardt. 'It's an honor to join this team and help scale a model that brings high-quality, virtual care to every corner of the nation.' This appointment comes at a time of unprecedented momentum for Avel eCare. In the past two years alone, Avel has launched new service lines, secured exclusive partnerships with organizations like Amwell and Cibolo Health, and expanded services to more than 46 states. The company continues to innovate with in-ambulance telehealth, ICU solutions, and programs that support EMS, law enforcement, and correctional health, making care more accessible, cost-effective, and consistent, especially in rural and underserved areas. The new CFO joins an accomplished executive team committed to advancing healthcare access and outcomes across the country. Avel's leadership includes: About Avel eCare Avel eCare is a national leader in technology-enabled clinical services delivered through telemedicine, offering provider-to-provider virtual care solutions that expand clinical capacity and improve outcomes across the healthcare industry. With more than 30 years of innovation, Avel's board-certified clinicians partner with hospitals, clinics, long-term care facilities, schools, EMS agencies, and correctional health systems nationwide to bring high-quality care to patients when and where it's needed most. Learn more at: Media Contact: Jessica Gaikowski Avel eCare [email protected] SOURCE: Avel eCare press release